Lupin Pharmaceuticals Inc. recalls Rifampin Capsules USP 300mg, 30-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Marylan
Recalled February 7, 2024 · FDA recall D-0284-2024 · Lupin Pharmaceuticals
Hazard
Subpotent Drug and Failed Impurities/Degradation Specifications · FDA Class II
Units
165,60 bottles
Sold at
Product was distributed to 32 Wholesale/distributor accounts who further distributed the product to 156 distribution sites.
Description
Subpotent Drug and Failed Impurities/Degradation Specifications
Product
Rifampin Capsules USP 300mg, 30-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States, Manufactured Lupin Limited, Aurangabad 431 210 INDIA, NDC 68180-659-06
Manufacturer(s)
Lupin Pharmaceuticals Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →